ORBIMED ADVISORS LLC 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:25 pm Sale |
2022-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
ORBIMED ADVISORS LLC | 80,421 2.400% |
-86,369 (-51.78%) |
Filing |
| 2022-02-11 4:26 pm Purchase |
2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
ORBIMED ADVISORS LLC | 166,790 5.100% |
64,720 (+63.41%) |
Filing |
| 2021-02-12 4:49 pm Sale |
2020-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
ORBIMED ADVISORS LLC | 102,070 4.020% |
-34,000 (-24.99%) |
Filing |